Ethacrynic Acid Tablet
Product Images NDC 68180-159

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethacrynic Acid (NDC 68180-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (D0df415d Bc9d 44f4 Bca8 F7f3d8628619 01)

FDA Label Image

Image 3 (D0df415d Bc9d 44f4 Bca8 F7f3d8628619 02)

Image 3 (D0df415d Bc9d 44f4 Bca8 F7f3d8628619 02)
This is a description for a medication with NDC 68180-159-01. Each tablet of this medication contains 25 m of ethacrynic acid, USP. The medication is manufactured by Lupin Pharmaceuticals, Inc. in the United States. The usual dosage and storage instructions are included in the accompanying package insert. The medication should be stored in a tightly closed container at 20°C to 25°C with excursions permitted to 15° to 30°C. The medication is dispensed in a well-closed container and the package is not child-resistant. The medication comes in a bulk package of 100 tablets and is for prescription use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.